The nebulous diagnosis of type III hereditary angioedema

Annals of Allergy, Asthma and Immunology

Volumn 111, Issue 1, 2013, Pages 65-66

  Fernando, Suran L ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR;

ANGIONEUROTIC EDEMA; CLINICAL FEATURE; DISEASE SEVERITY; DRUG TARGETING; FACTOR XII GENE; FAMILY HISTORY; GENE; GENE MUTATION; HUMAN; LETTER; NON HISTAMINERGIC IDIOPATHIC ANGIOEDEMA; PATHOGENESIS; PRIORITY JOURNAL; URTICARIA;

EID: 84879551832     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.04.006     Document Type: Article

References (7)

1. C. Marcos, A.L. Lera, and S. Varela Type III hereditary angioedema: clinical, biochemical, and genetic characterization in thirteen northwest Spanish families Ann Allergy Asthma Immunol 109 2012 195 200
2. A. Kaplan Type III hereditary angioedema: defined, but not understood Ann Allergy Asthma Immunol 109 2012 153 154
3. D.G. Ebo, and C.H. Bridts Images in clinical medicine: disfiguring angioedema N Engl J Med 367 2012 1539
4. B.L. Zuraw, and S.C. Christiansen Pathogenesis and laboratory diagnosis of hereditary angioedema Allergy Asthma Proc 30 2009 487 492
5. K. Bork, R. Kleist, and J. Hardt Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys Blood Coagul Fibrinolysis 20 2009 325 332
6. E.M. Gordon, O.D. Ratnoff, and H. Saito Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives J Lab Clin Med 96 1980 762 769
7. K. Binkley Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions Allergy Asthma Clin Immunol 6 2010 16